ロード中...
Diarrhoea in a patient with metastatic melanoma: Ipilimumab ileocolitis treated with infliximab
Administration of ipilimumab, a cytotoxic T-lymphocyte associated antigen-4-blocking monoclonal antibody, leads to enhancement of the anti-tumor T-cell respons and as a result shows a significant survival benefit in metastatic melanoma patients. Therefore patients are currently receiving this promis...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3729871/ https://ncbi.nlm.nih.gov/pubmed/23919220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v4.i3.80 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|